Skip to main content
. 2012 Sep 5;13:78. doi: 10.1186/1471-2350-13-78

Table 1.

Patient characteristics

ESRD patients, n = 1142  
 Age, years
47.7 ± 13.5
 Sex: male, n (%)
662 (58.0)
 Primary disease:
 
 - glomerulonephritis, n (%)
242 (21.2)
 - autosomal dominant polycystic kidney disease, n (%)
155 (13.6)
 - pyelonephritis, n (%)
128 (11.2)
 - renal vascular disease, n (%)
110 (9.6)
 - IgA nephropathy, n (%)
89 (7.8)
 - diabetes types I and II, n (%)
47 (4.1)
 - other/uncertain etiology, n (%)
371 (32.5)
Kidney donors, n = 1184
 
 Age, years
44.5 ± 14.3
 Sex: male, n (%)
602 (50.8)
 Living donors, n (%)
282 (23.8)
 - from which related donors, n (%)
164 (58.2)
Matched donor-recipient pairs, n = 1066
 
 Recipient age, years
48.1 ± 13.5
 Recipient sex: male, n (%)
620 (58.2)
 Donor age, years
44.6 ± 14.3
 Donor sex: male, n (%)
540 (50.7)
 Living donors, n (%)
261 (24.5)
 Cold ischemia time, hours
17.4 [9.0-23.0]
 Total warm ischemia time, minutes
40.0 [34.0-51.0]
 Delayed graft function, n (%)
332 (31.1)
 Post-transplant follow-up duration, years
5.5 [3.0-8.7]
 Acute organ rejection episodes history, n (%)
368 (34.5)
 Death-censored graft failure, n (%)
172 (16.1)
 Death with a functioning graft, n (%)
182 (17.1)
Renal transplant recipients with urine available, n = 282
 
 Age, years
52.1 ± 12.3
 Sex: male, n (%)
152 (53.9)
 Urine collection time point, years after transplantation 4.2 [2.2-6.1]

Continuous normally distributed variables are presented as means ± SD, non-normally distributed – as medians [IQR].